|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBOOKCENTRAL_ocn903015371 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
150209s2014 nyua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d IDEBK
|d CDX
|d E7B
|d EBLCP
|d OCLCQ
|d YDXCP
|d OCLCQ
|d UAB
|d YDX
|d MOR
|d OCLCQ
|d OCLCO
|d OCLCA
|d AU@
|d OCLCQ
|d MERUC
|d OCLCO
|d ZCU
|d OCLCO
|d VT2
|d USU
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d SFB
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 905862247
|a 1117867765
|a 1290075368
|
020 |
|
|
|a 9780199988143
|q (electronic bk.)
|
020 |
|
|
|a 0199988145
|q (electronic bk.)
|
020 |
|
|
|a 0199988153
|
020 |
|
|
|a 9780199988150
|
020 |
|
|
|z 9780199988136
|
020 |
|
|
|z 0199988137
|
029 |
1 |
|
|a DEBBG
|b BV042795587
|
035 |
|
|
|a (OCoLC)903015371
|z (OCoLC)905862247
|z (OCoLC)1117867765
|z (OCoLC)1290075368
|
037 |
|
|
|a 1808773
|b Proquest Ebook Central
|
050 |
|
4 |
|a RC280.K5
|b R46 2014eb
|
060 |
|
4 |
|a WJ 358
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99/461
|2 23
|
049 |
|
|
|a UAMI
|
130 |
0 |
|
|a Renal cell carcinoma (Tannir)
|
245 |
1 |
0 |
|a Renal cell carcinoma /
|c edited by Nizar M. Tannir.
|
264 |
|
1 |
|a New York, NY :
|b Oxford University Press,
|c [2014]
|
300 |
|
|
|a 1 online resource (xiv, 194 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Oxford American oncology library
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Epidemiology of renal cell carcinoma / Xifeng Wu, Xiang Shu, Wong-Ho Chow, and Jian Gu -- Pathology of renal cell carcinoma / Priya Rao and Pheroze Tamboli -- Biology of renal cell carcinoma / Thai H. Ho, Ruhee Dere, and Cheryl L. Walker -- Inherited renal cell cancers / Eric Jonasch and Sarathi Kalra -- Interventional radiology procedures in renal cell carcinoma / Sharjeel H. Sabir and Alda L. Tam -- Management of small renal masses and early-stage renal cell carcinoma / Surena F. Matin -- Staging and surgical management of locally advanced renal cell carcinoma and the role of adjuvant and neoadjuvant therapy / Dae Y. Kim, Jose A. Karam, and Christopher G. Wood -- Integration of targeted therapy with cytoreductive nephrectomy and metastasectomy in the management of metastatic renal cell carcinoma / Bishoy A. Gayed, Jose A. Karam, Vitaly Margulis, and Christopher G. Wood -- Immunotherapeutic approaches for metastatic conventional-type renal cell carcinoma / Anasuya Gunturi and David F. McDermott -- Targeted therapies for metastatic conventional-type renal cell carcinoma / Tim Eisen and Ferdinandos Skoulidis -- Systemic therapies for metastatic renal cell carcinoma of variant histology -- Sumanta K. Pal and Toni K. Choueiri -- Prognostic and predictive biomarkers in renal cell carcinoma / David D. Chism and W. Kimryn Rathmell -- Management of complications of targeted therapies for metastatic renal cell carcinoma / Bradley Atkinson and Diana Cauley -- The role of traditional and stereotactic radiation in metastatic renal cell carcinoma / Amol J. Ghia and Seungtaek Choi -- Supportive care in advanced renal cell carcinoma / Sriram Yennurajalingam -- Integrative medicine in the management of renal cell carcinoma / Alejandro Chaoul, Gabriel Lopez, Richard Lee, M. Kay Garcia, Lorenzo Cohen -- Emerging therapies and future directions in renal cell carcinoma / George K. Philips and Michael B. Atkins.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a While patients with metastatic renal cell carcinoma (mRCC) are now living longer with improved quality of life, the success of novel therapies for mRCC has created challenges for practicing oncologists. Many patients who initially respond to targeted therapies ultimately develop progressive disease due to acquired resistance to these agents. Additionally, some patients do not respond at all to any of the currently approved targeted agents, underscoring the need for continued and concerted efforts to identify other relevant targets and pursue alternative therapeutic strategies. This is a concise handbook that addresses the complex management of patients with mRCC. The book begins with a review of the epidemiology, pathology, and biology of renal cell carcinoma followed by chapters on specific targeted therapies and managing complications. The final chapters discuss supportive and integrative care and emerging therapies.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Renal cell carcinoma.
|
650 |
1 |
2 |
|a Carcinoma, Renal Cell
|
650 |
2 |
2 |
|a Kidney Neoplasms
|
650 |
2 |
2 |
|a Molecular Targeted Therapy
|x methods
|
650 |
|
6 |
|a Néphrocarcinome.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Renal cell carcinoma
|2 fast
|
700 |
1 |
|
|a Tannir, Nizar M.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|a Renal cell carcinoma (Tannir).
|t Renal cell carcinoma
|z 9780199988136
|w (DLC) 2014010925
|w (OCoLC)874093441
|
830 |
|
0 |
|a Oxford American oncology library.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1808773
|z Texto completo
|
938 |
|
|
|a Coutts Information Services
|b COUT
|n 30970462
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL1808773
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr11019598
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 948389
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis30970462
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 12287392
|
994 |
|
|
|a 92
|b IZTAP
|